MRNS
Marinus Pharmaceuticals Inc
Biopharmaceutical company focused on seizure disorder therapeutics
CUSIP: 56854Q200HealthcareUS1 holder
Marinus Pharmaceuticals Inc
Biopharmaceutical company focused on seizure disorder therapeutics
No financial data available for this security.